Therapeutic Asset Ratings
223 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Atlcar.Cd30.Ccr4 Cells
Sezary Syndrome
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Bendamustine
Sezary Syndrome
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Car.B7-H3T Cells Infusion
Glioblastoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Car.K.28
Indolent B-Cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Car.K.28
Splenic Marginal Zone Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Chimeric Antigen Receptor Modified T Cells Infusion
Cutaneous T Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Chimeric Antigen Receptor Modified T Cells Infusion
Mycosis Fungoides
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Chimeric Antigen Receptor Modified T Cells Infusion
Sezary Syndrome
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
ic9.gd2.car.il-15 t-cells
Neuroblastoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
ic9.gd2.car.il-15 t-cells
Osteosarcoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Panda-Vac
Head And Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Zofran
Sezary Syndrome
UNC Lineberger Comprehensive Cancer Center
P1
CC
(41)
Atezolizumab
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(40)
Abequolixron
Non-Small Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Car.B7-H3
Ovarian Carcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Dordaviprone
Carcinosarcoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Dordaviprone
Endometrial Clear Cell Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Dordaviprone
Endometrial Mixed Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Dordaviprone
Endometrial Endometrioid Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Dordaviprone
Endometrial Serous Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
ic9-car19 t cells
B-Cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
ic9-car.b7-h3 t cells
Ovarian Carcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
ic9-car.b7-h3 t cells
Malignant Pancreatic Neoplasm
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Rimiducid
B-Cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(39)
Dordaviprone
Metastatic Neoplasm
UNC Lineberger Comprehensive Cancer Center
P1
C
(38)
Showing 176 to 200 of 223 assets
Previous
Page 8 of 9
Next